Cases & Deals

  • Home
  • Practices
  • Bpifrance leads €43 million Series B financing of LATTICE MEDICAL

Share

Bpifrance leads €43 million Series B financing of LATTICE MEDICAL

October 2025

Client(s) Bpifrance

Jones Day advised Bpifrance, through its SPI 2 fund, in the €43 million Series B financing of LATTICE MEDICAL, a French Medtech company specializing in tissue engineering, enabling the company to accelerate the clinical development of its MATTISE medical device, a breakthrough innovation in post-cancer breast reconstruction.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.